{
  "ticker": "PTX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969334",
  "id": "02969334",
  "pages": 5,
  "price_sensitive": true,
  "date": "20250715",
  "time": "0918",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250715/pdf/06lt1lb0n266t7.pdf",
  "summary": "### Key Material Information (Capital Raising Announcement):  \n\n- **Structure**: Share Purchase Plan (SPP)  \n- **Target Raise**: Up to **$7 million** at **$0.040 per share** (16.7% discount to 15-day VWAP prior to announcement).  \n- **Use of Proceeds**: Advance **PTX-100** through Phase 2 clinical development.  \n- **Key Dates**:  \n  - **Revised Closing Date**: 22 July 2025 (5pm AEST).  \n  - **Results Announcement**: 28 July 2025.  \n  - **Issue/Trading of SPP Shares**: 30\u201331 July 2025.  \n- **Eligibility**: Shareholders on record as of **30 June 2025** (max. $30,000 per holder).  \n\n*Omitted: Event schedules, contact details, background on therapies, legal disclaimers.*",
  "usage": {
    "prompt_tokens": 2648,
    "completion_tokens": 196,
    "total_tokens": 2844,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-14T23:44:21.900950"
}